Research ArticleExperimental Studies

Cytotoxicity and Cellular Uptake of Doxorubicin and its Formamidine Derivatives in HL60 Sensitive and HL60/MX2 Resistant Cells

KRZYSZTOF KIK, MALGORZATA WASOWSKA-LUKAWSKA, IRENA OSZCZAPOWICZ and LESZEK SZMIGIERO
Anticancer Research April 2009, 29 (4) 1429-1433;

Article Information

vol. 29 no. 4 1429-1433
PMID 
19414398
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received November 27, 2008
  • Revision received January 14, 2009
  • Accepted February 2, 2009
  • Published online April 1, 2009.
Copyright & Usage 
Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. KRZYSZTOF KIK1,
  2. MALGORZATA WASOWSKA-LUKAWSKA2,
  3. IRENA OSZCZAPOWICZ2 and
  4. LESZEK SZMIGIERO1
  1. 1Department of Molecular Pharmacology, Medical University of Lodz, 92-215 Lodz
  2. 2Institute of Biotechnology and Antibiotics, 02-516 Warsaw, Poland
  1. Correspondence to: Leszek Szmigiero, Department of Molecular Pharmacology, Medical University of Lodz, 6/8 Mazowiecka St., 92-215 Lodz, Poland. Tel: +48 42 6790450, Fax: +48 42 6784277, e-mail: chemgen{at}csk.umed.lodz.pl
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Cytotoxicity and Cellular Uptake of Doxorubicin and its Formamidine Derivatives in HL60 Sensitive and HL60/MX2 Resistant Cells
KRZYSZTOF KIK, MALGORZATA WASOWSKA-LUKAWSKA, IRENA OSZCZAPOWICZ, LESZEK SZMIGIERO
Anticancer Research Apr 2009, 29 (4) 1429-1433;
Twitter logo Facebook logo Mendeley logo

Jump to section